Independent Researcher, San Rafael, USA.
Disease Prevention and Control, San Francisco Department of Public Health, San Francisco, CA, USA.
AIDS Behav. 2020 Sep;24(9):2509-2519. doi: 10.1007/s10461-020-02807-3.
PrEP persistence, or PrEP use over time, has been shown to be short, with most PrEP users stopping within 6-12 months. Furthermore, those most vulnerable to HIV often use PrEP for shorter periods. This qualitative study explores patient, provider, and contextual factors that influence PrEP persistence. In interviews with 25 PrEP users and 18 PrEP providers in San Francisco's safety net clinics, we analyze the perceived benefits and difficulties of taking PrEP, including structural barriers. We identify different steps in receipt of PrEP care (clinic visits and lab tests, pharmacy interactions, and medication adherence), and describe barriers and facilitators for providers and patients at each step. Our findings suggest that drop-in visits, streamlined testing, standing orders for labs, and 90-day PrEP prescriptions are highly desirable for many PrEP users. Also important are the proactive provision of adherence support and counseling, and referrals for housing, substance use, and mental health services.
PrEP 持续用药,即一段时间内持续使用 PrEP,时间通常很短,大多数 PrEP 用户在 6-12 个月内停止用药。此外,那些感染 HIV 风险最高的人群往往使用 PrEP 的时间更短。本定性研究探讨了影响 PrEP 持续用药的患者、医护人员和环境因素。我们对旧金山的安全网诊所中 25 名 PrEP 用户和 18 名 PrEP 医护人员进行了访谈,分析了服用 PrEP 的益处和困难,包括结构性障碍。我们确定了接受 PrEP 护理的不同步骤(诊所就诊和实验室检查、药房互动和药物依从性),并描述了每个步骤中医护人员和患者的障碍和促进因素。研究结果表明,对于许多 PrEP 用户来说,随到随诊、简化检测、实验室检测的常规医嘱和 90 天 PrEP 处方非常受欢迎。此外,积极提供药物依从性支持和咨询,以及住房、药物使用和心理健康服务的转介也很重要。